πŸ‡ΊπŸ‡Έ FDA
Patent

US 11932617

Compound for use in retinal diseases

granted A61PA61P27/00A61P27/02

Quick answer

US patent 11932617 (Compound for use in retinal diseases) held by ZHUHAI UNITED LABORATORIES CO., LTD. expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ZHUHAI UNITED LABORATORIES CO., LTD.
Grant date
Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P27/00, A61P27/02